Who is sponsoring NCT02421757?

NCT02421757 is sponsored by University of Maryland, Baltimore.

What condition does NCT02421757 study?

NCT02421757 studies Lower Back Pain.

Is NCT02421757 still recruiting?

NCT02421757 is currently completed. Last updated 23 November 2021.

Are results published for NCT02421757?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-11-23 · How we verify

NCT02421757

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)

Completed NA Results posted Last updated 23 November 2021

What this trial tests

NA trial testing Fischell Transcutaneous Magnetic Stimulation Pain Treatment Device in Lower Back Pain in 20 participants. Completed in 22 June 2017.

Timeline

22 August 2016

Primary endpoint
22 June 2017

22 June 2017

Quick facts

Lead sponsor	University of Maryland, Baltimore
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	22 August 2016
Primary completion	22 June 2017
Estimated completion	22 June 2017
Sites	1 location across United States

Drugs / interventions tested

Fischell Transcutaneous Magnetic Stimulation Pain Treatment Device
Placebo

Conditions studied

Lower Back Pain — all drugs for Lower Back Pain →

Sponsor

University of Maryland, Baltimore

Who can join

18 and older, any sex, with Lower Back Pain. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Immediate Pain Measured by Numeric Pain Rating Scale (NPRS) Primary · 60 minutes

Immediate relief measured by Numeric Pain Rating Scale (NPRS) Scale from 0-10 0=No pain 10= Worse possible pain

Group	Value	95% CI
Transcutaneous Magnetic Stimulation	4.89	0 – 10
Sham Device	5.18	0 – 10

Durable Pain Measured by Numeric Pain Rating Scale (NPRS) Secondary · 30 days

Durable pain relief measured by Numeric Pain Rating Scale (NPRS) 0= No pain 10= Worse imaginable pain

Group	Value	95% CI
Transcutaneous Magnetic Stimulation	6.00	0 – 10
Sham Device	6.57	0 – 10

Sponsor's own description

This is a single-site, randomized, Single-blinded, placebo-controlled, trial of Transcutaneous Magnetic Stimulation (TCMS) for the treatment of lower back pain. TCMS will be applied locally to the back in the location of a patient's pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lower Back Pain

Currently open trials in the same condition.

NCT07166952 — Peripheral Nerve Stimulation With the SPRINT® System in Chronic PSIJC Pain · NA · recruiting
NCT07062510 — The Effects of Balanced Seating Pressure on Pelvic Asymmetry: A Pilot Study · NA · recruiting
NCT07197879 — Effect of Dynamic Sitting on Pain Development - Part 2 · NA · recruiting
NCT06225583 — Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers · active not recruiting
NCT03707288 — Neck and Low Back Pain in Medical Students at The University of the West Indies, Mona, Jamaica · NA · recruiting

Other University of Maryland, Baltimore trials

Trials by the same sponsor.

NCT07537413 — Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia · Phase 4 · not yet recruiting
NCT07221799 — OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis · Phase 1 · not yet recruiting
NCT07094672 — Development of an Opioid Withdrawal Clinical Outcome Assessment · not yet recruiting
NCT06583239 — Hub-Based Engagement Navigator Service to Reduce CSC Disengagement · NA · not yet recruiting
NCT07536412 — Decision Aid Efficacy in Low Risk Thyroid Cancer · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02421757 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Maryland, Baltimore
Last refreshed: 23 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02421757.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing